Top story

RFK Jr. to Allow Broad Use of Unapproved Peptide Injections

In a unilateral declaration by the health secretary, several injections promoted by online influencers will become widely available. The F.D.A. had advised against the move.

Read full story

EASD 2026: CagriSema weight loss holds at submaximal doses in REDEFINE-1 analysis

Pharmaceutical Technology
By GlobalData Healthcare - Wed, 30 Sep 2026
Read more

OBIO marks $704m funding milestone for Canadian health tech ventures

Pharmaceutical Technology
By Salong Debbarma - Wed, 30 Sep 2026
Read more

Leading CDMO to attend CPHI Milan 2026 in Italy

Pharmaceutical Technology
By Alexander Love - Wed, 30 Sep 2026
Read more

Atossa plans shareholder stake in potential PRV proceeds

Pharmaceutical Technology
By Robert Barrie - Wed, 30 Sep 2026
Read more

EASD 2026: Tirzepatide outperforms semaglutide in real-world type 2 diabetes analysis

Pharmaceutical Technology
By GlobalData Healthcare - Wed, 30 Sep 2026
Read more

Strengthening Regulation of Traditional Medicine for Safer Healthcare

Pharmacy and Poisons Board
By Public Relations - September 1, 2026
Read more

Building Confidence in African Traditional Medicines

Pharmacy and Poisons Board
By Public Relations - September 1, 2026
Read more

F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

The New York Times - Drugs & Pharmaceuticals
By Gina Kolata, Rebecca Robbins and Carolyn Y. Johnson - Wed, 26 Aug 2026
Read more

Trump Will End Subsidies for Medicare Drug Premiums

The New York Times - Drugs & Pharmaceuticals
By Rebecca Robbins and Reed Abelson - Wed, 29 Jul 2026
Read more